<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: In <z:hpo ids='HP_0001639'>hypertrophic cardiomyopathy</z:hpo> (HCM), the arrhythmic potential associated with a variety of left ventricular myocardial signal intensities evident on contrast-enhanced cardiovascular magnetic resonance with late <z:chebi fb="0" ids="33375">gadolinium</z:chebi> enhancement (LGE) is unresolved </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS AND RESULTS: In 145 HCM patients (43±15 years old), visually identified areas of LGE in left ventricle were analyzed quantitatively for intermediate (≥4 but &lt;6 SD) and high (≥6 SD above the mean signal intensity of <z:mpath ids='MPATH_458'>normal</z:mpath> myocardium) LGE signal intensity (LGE-SI) </plain></SENT>
<SENT sid="2" pm="."><plain>Ambulatory Holter ECGs were obtained within 7.8±8.3 weeks of cardiovascular magnetic resonance </plain></SENT>
<SENT sid="3" pm="."><plain>HCM patients with nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, ventricular couplets, and <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo> showed greater amounts of intermediate LGE-SI (17±7 versus 10±10 g, 16±10 versus 10±11 g, and 13±8 versus 10±13 g, respectively; P=0.003 to &lt;0.001) and greater amounts of high LGE-SI (15±6 versus 10±8 g, 14±9 versus 10±12 g, and 12±7 versus 10±8 g, respectively; P=0.02-0.003) than patients without these <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In HCM patients with either nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, couplets, or <z:hpo ids='HP_0006682'>premature ventricular contractions</z:hpo>, the extent of intermediate LGE-SI exceeded that of high LGE-SI (17±7 versus 15±6 g, 16±10 versus 14±9 g, and 13±8 versus 12±7 g, respectively; P=0.01-0.04) </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, the receiver operating characteristic area under the curve established intermediate LGE-SI as a better discriminator of patients with nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo> than was high LGE-SI, with 7 additional patients with this <z:hpo ids='HP_0011675'>arrhythmia</z:hpo> identified </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: In patients with HCM, intermediate LGE-SI is a better predictor of ventricular tachyarrhythmias (including nonsustained <z:hpo ids='HP_0004756'>ventricular tachycardia</z:hpo>, a risk factor for <z:hpo ids='HP_0001699'>sudden death</z:hpo>) than is high LGE-SI </plain></SENT>
<SENT sid="7" pm="."><plain>Longitudinal studies in larger HCM cohorts are justified to define the independent prognostic impact of intermediate LGE-SI </plain></SENT>
</text></document>